HENRY BARTOS, M.D.; JANE F. DESFORGES, M.D.; WILLIAM C. MOLONEY, M.D.
In an attempt to elucidate the cause of increased glucose 6-phosphate dehydrogenase (G6PD) in patients with myelofibrosis, the spleen size, red cell survival, and erythrocyte glutamic-oxaloacetic transaminase levels were correlated with G6PD levels in a group of nine patients with this disorder. The evidence indicates that the patients with increased G6PD had a young erythrocyte population, while those with normal G6PD did not. It was concluded that the G6PD elevation, when it occurred, was reflecting cell age changes, and was probably without pathogenetic significance. Furthermore, the data suggest that G6PD might be clinically useful in evaluating the rate of erythrocyte production in myelofibrotic patients.
Learn more about subscription options.
Register Now for a free account.
BARTOS H, DESFORGES JF, MOLONEY WC. Red Cell Enzymes in the Anemia of Myelofibrosis. Ann Intern Med. 1968;68:533–538. doi: 10.7326/0003-4819-68-3-533
Download citation file:
Published: Ann Intern Med. 1968;68(3):533-538.
Hematology/Oncology, Red Cell Disorders.
Results provided by:
Copyright © 2017 American College of Physicians. All Rights Reserved.
Print ISSN: 0003-4819 | Online ISSN: 1539-3704
Conditions of Use
This PDF is available to Subscribers Only